1) breast reconstruction surgery option
There's a new single-step breast reconstruction surgery option available for some women having a mastectomy. Breast tissue is removed and reconstructed in one step so women wake up from the surgery with a full figure.
2) lead less cardiac pacemaker
Since 1958, the technology involved in cardiac pacemakers hasn't changed much. A silver-dollar sized pulse generator and a thin wire or lead inserted through the vein kept the heart beating at a steady pace. Leads, though, can break and crack, and become infection sites in 2% of cases. Vitamin-sized wireless cardiac pacemakers can be implanted directly in the heart without surgery and eliminate malfunction complications and restriction on daily physical activities.
3) new drug for heart failure
Angiotensin-receptor neprilysin inhibitor or ARNI has been granted "fast-track status" by the FDA because of its impressive survival advantage over the ACE inhibitor enalapril, the current "gold standard" for treating patients with heart failure. The unique drug compound represents a paradigm shift in heart failure therapy.
4) PCSK9 inhibitors for cholesterol reduction
Effective statin medications has been used to reduce cholesterol in heart disease patients for over 2 decades, but some people are intolerant and cannot benefit from them. Several PCSK9 inhibitors, or injectable cholesterol lowering drugs are in development for those who don't benefit from statins. The FDA is expected to approve the first PCSK9 in 2015 for its ability to significantly lower LDL cholesterol to levels never seen before.
5) dengue fever vaccine
One mosquito bite is all it takes. More than 50 to 100 million people in more than 100 countries contract the dengue virus each year. The world's first vaccine has been developed and tested, and is expected to be submitted to regularly groups in 2015 with commercialization expected later that year.
6) cost-effective, fast, painless blood testing
Have the days of needles and vials come to an end? The new art of blood collection uses a drop of blood drawn from the fingertip in a virtually painless procedure. Test results are available within hours of the original draw and are estimated to cost as little as 10% of the traditional Medicare reimbursement.
7) innovation in breast cancer detection
Approved by the FDA Feb 11,2011 breast tomosynthesis, a new imaging technology pioneered by the MGH Breast Imaging Program under the leadership of Elizabeth Rafferty, MD, director of Breast Imaging at MGH, produces a 3D of the breast and gives doctors a clearer view through the overlapping structures of breast tissue.
8) new drugs for idiopathic pulmonary fibrosis
Nearly 80,000 American adults with idiopathic pulmonary fibrosis may breathe easier in 2015 with the recent FDA-approval of two new experimental drugs. Pirfenidone and nintedanib slow the disease progress of the lethal lung disease, which causes scarring of the air sacs. Prior to this developments, there was no known treatment for IPF where life expectancy after diagnosis is just 3 to 5 years.
9) modular devices for complex aneurysm treatment
This off-the-shelf fenestrated device has a four-piece modular design: a proximal tubular component with fenestrations, a second bifurcated component without a top cap, and two iliac limbs. The device is based on the fenestrated platform for elective patients. The standardized location of the fenestration is expected to accommodate anatomy for approximately 70% of patients with less than 10 variations of the proximal piece. Vascular surgeons at the Cleveland Clinic have recently performed the initial first-in-human procedures in the US with off-the-shelf fenestrated endografts for patients with juxtarenal and type IV TAAAs. The new device formed by covered balloon-expandable stents to both renal arteries and the superior mesenteric artery.
10) ex vivo lung perfusion
For decades, heart and lung transplant surgeons have followed a strict directive: get the donor organ into the recipient as soon as possible. Currently, only about 15%-20% of donor lungs are acceptable for transplantation since lungs are susceptible to injuries during the brain-death process or from intensive care unit-related lung complications. These numbers can easily be doubled with the Ex Vivo Lung Perfusion used to treat and improve donor lungs.
~PLEASE ENJOY WHILE WATCHING THESE VIDEOS~
HOPE IT BENEFICIAL FOR YOU
TQ:)
No comments:
Post a Comment